Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia

Clin Infect Dis. 2000 Mar;30(3):520-8. doi: 10.1086/313716.

Abstract

The impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia was evaluated in a retrospective cohort study conducted during population-based surveillance for invasive pneumococcal disease in the greater Atlanta region during 1994. Of the 192 study patients, 44 (23%) were infected with pneumococcal strains that demonstrated some degree of penicillin nonsusceptibility. Compared with patients infected with penicillin-susceptible pneumococcal strains, patients whose isolates were nonsusceptible had a significantly greater risk of in-hospital death due to pneumonia (relative risk [RR], 2.1; 95% confidence interval [CI], 1-4.3) and suppurative complications of infection (RR, 4.5; 95% CI, 1-19.3), although only risk of suppurative complications remained statistically significant after adjustment for baseline differences in severity of illness. Among adults with bacteremic pneumococcal pneumonia, infection with penicillin-nonsusceptible pneumococci is associated with an increased risk of adverse outcome.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Bacteremia / drug therapy*
  • Bacteremia / microbiology
  • Bacteremia / mortality
  • Cohort Studies
  • Community-Acquired Infections / drug therapy
  • Community-Acquired Infections / microbiology
  • Female
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Penicillins / pharmacology*
  • Penicillins / therapeutic use
  • Pneumonia, Pneumococcal / drug therapy*
  • Pneumonia, Pneumococcal / microbiology
  • Pneumonia, Pneumococcal / mortality
  • Retrospective Studies
  • Severity of Illness Index
  • Streptococcus pneumoniae / drug effects*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Penicillins